Yun-shi Cai
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Alternative splicing: from tumorigenesis to neoantigen-mediated cancer immunotherapy.
Journal: Biomarker research
Published: August 26, 2025
Case Report: Dual checkpoint inhibition with bevacizumab yields dramatic response in synchronous double primary HCC and ICC with lung metastasis.
Journal: Frontiers in oncology
Published: July 22, 2025
Living Donor Liver Transplantation Versus Deceased Donor Liver Transplantation for Hepatocellular Carcinoma and HCV Patients: An Initial Umbrella Review.
Journal: Journal of clinical medicine
Published: February 17, 2025
Predicting prognosis in intrahepatic cholangiocarcinoma by the histopathological features.
Journal: Asian journal of surgery
Published: September 12, 2023
Liver Transplant for Alcohol-Associated Liver Disease.
Journal: JAMA surgery
Published: January 05, 2022
Benefit of a Live Donor for Patients With Hepatocellular Carcinoma on the Waiting List.
Journal: JAMA surgery
Published: December 15, 2021
Is FOLFOX-HAIC superior to transarterial chemoembolization in treating large hepatocellular carcinoma?
Journal: Hepatobiliary surgery and nutrition
Published: November 29, 2021
Donafenib as a first-line monotherapy for advanced hepatocellular carcinoma.
Journal: Hepatobiliary surgery and nutrition
Published: July 23, 2021
Letter to the Editor: Statin Reduces the Risk of Hepatocellular Carcinoma Development in Patients With CHB.
Journal: Hepatology (Baltimore, Md.)
Published: September 23, 2020
Anatomical and Extra-anatomical Hepatic Artery Reconstruction During Living Donor Liver Transplantation: Is It Reasonable to Classify This Way?
Journal: Transplantation
Published: January 14, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026